Abingworth’s Achieve Life Sciences ACHV Stock Holding History

Abingworth’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-180	Closed	-$195K	–	18
2016 Q3	$195K	Hold	180	–	–	0.19%	20
2016 Q2	$400K	Hold	180	–	–	0.42%	19
2016 Q1	$271K	Hold	180	–	–	0.25%	17
2015 Q4	$475K	Sell	180 -94	-34%	-$397K	0.29%	17
2015 Q3	$1.33M	Hold	274	–	–	0.78%	14
2015 Q2	$1.41M	Hold	274	–	–	0.64%	14
2015 Q1	$1.27M	Hold	274	–	–	0.54%	14
2014 Q4	$1.35M	Hold	274	–	–	0.38%	14
2014 Q3	$1.6M	Hold	274	–	–	0.96%	10
2014 Q2	$2.23M	Hold	274	–	–	1.04%	9
2014 Q1	$7.09M	Hold	274	–	–	3.91%	7
2013 Q4	$5.04M	Hold	274	–	–	3.79%	7
2013 Q3	$5.61M	Hold	274	–	–	3.2%	6
2013 Q2	$5.92M	Buy	+274	New	+$6.13M	4.55%	5

Other funds holding ACHV

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Abingworth's ACHV Position: Q4 2016 in Review

Abingworth sold out of Achieve Life Sciences (ACHV) in Q4 2016, closing a stake of 180 shares — an estimated $195K sold.

Abingworth first reported a position in ACHV in Q2 2013 and held it in 14 quarters. The position peaked at $7.09M in Q1 2014. 29 funds tracked by Wall St. Rank hold ACHV as of Q4 2016.

Abingworth reported no remaining Achieve Life Sciences position as of Q4 2016 after selling out during the quarter.
Abingworth sold 180 Achieve Life Sciences shares in Q4 2016, an estimated $195K.
Abingworth first reported a position in Achieve Life Sciences in Q2 2013 and held it in 14 quarters.
Abingworth's Achieve Life Sciences position peaked at $7.09M in Q1 2014.
29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2016.

Based on Abingworth's 13F filing for Q4 2016, filed 14 Feb 2017.